(Q73370918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

Y Lecrubier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P Boyer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Turjanski

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W Rein

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 April 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

Journal of Affective Disorders

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

95-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

Treatment of negative symptoms in schizophrenia with amisulpride

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

Imipramine treatment for chronic depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

Improvement of some schizophrenic deficit symptoms with low doses of amisulpride

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

Response to phenelzine and amitriptyline in subtypes of outpatient depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2896%2900103-6

7 January 2021

10.1016/S0165-0327(96)00103-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9165379%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference